Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7026 studies found for:    vaccine
Show Display Options
Rank Status Study
21 Completed Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
Condition: Influenza
Intervention: Biological: Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008
22 Unknown  The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis
Conditions: Immunogenicity and Adverse Drug Effect of Vaccines Influenza;   Chronic Kidney Disease
Intervention: Biological: Seasonal influenza vaccine (AdimFlu-S)
23 Completed
Has Results
Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants
Condition: Meningococcal Disease
Interventions: Biological: rMenB;   Biological: rMenB+OMV
24 Completed Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine
Condition: Group B Streptococcus Infections
Intervention: Biological: GBS Vaccine
25 Completed Safety and Immunogenicity of 2 Commercially Available Influenza Vaccines in Children
Condition: Influenza
Intervention: Biological: Influenza vaccine
26 Completed Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010
Condition: Seasonal Influenza
Intervention: Biological: inactivated split influenza vaccine
27 Terminated
Has Results
Influenza Vaccine Post Allogeneic Transplant
Conditions: Hematopoietic Stem Cell Transplant;   Hematologic Malignancy
Intervention: Biological: Influenza vaccine
28 Enrolling by invitation Continued Safety and Immunogenicity Study of a Live Francisella Tularensis Vaccine
Condition: Tularemia
Intervention: Biological: Live Francisella Tularensis Vaccine
29 Completed
Has Results
Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
Condition: Influenza
Intervention: Biological: Inactivated H1N1 vaccine
30 Active, not recruiting Maternal Flu Vaccine Trial in Bamako, Mali
Condition: Influenza
Interventions: Biological: Inactivated Influenza Vaccine Trivalent Types A and B;   Biological: Meningococcal Polysaccharide-Diphtheria Toxoid Conjugate Vaccine
31 Completed
Has Results
Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly
Condition: Influenza
Interventions: Biological: Cell culture-derived trivalent subunit influenza vaccine (cTIV);   Biological: Egg-derived trivalent subunit influenza vaccine (TIV)
32 Active, not recruiting A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years
Conditions: Human Papillomavirus;   HIV-1 Infection
Intervention: Biological: Gardasil vaccine
33 Completed
Has Results
Risk of Narcolepsy Associated With Administration of H1N1 Vaccine
Condition: Narcolepsy
Intervention: Biological: A/H1N1 vaccine
34 Completed Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects
Conditions: Influenza;   Seasonal Influenza
Intervention: Biological: Seasonal Influenza Vaccine
35 Terminated Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults
Condition: Hookworm Infection
Intervention: Biological: Na-ASP-2 Hookworm Vaccine
36 Active, not recruiting Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia (CLL)
Intervention: Biological: Oncoquest-CLL vaccine
37 Completed Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella
Conditions: Rubella;   Measles
Intervention: Biological: Double viral (MR) vaccine
38 Completed Vaccine Study for Surgically Resected Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Biological: HyperAcute(R)-Pancreatic Cancer Vaccine
39 Completed Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine
Condition: Avian Influenza
Intervention: Biological: OrniFlu® inactivated vaccine
40 Completed
Has Results
Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012
Condition: Seasonal Influenza
Intervention: Biological: Seasonal Influenza Vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.